Update and Review,Proinsulin levels above 5 pmol/l with blood glucose levels below 2.5 mmol/l

Understanding the intricate relationship between proinsulin, insulin, and C-peptide is crucial for comprehending pancreatic function, particularly in the context of diabetes. While all three are intrinsically linked to glucose regulation, they offer distinct insights into how the body produces and utilizes this vital hormone. This article delves into the specifics of proinsulin vs. insulin vs. C-peptide, exploring their synthesis, roles, and clinical significance.

The Genesis of Insulin: From Proinsulin to Active Hormones

Insulin is a hormone produced by the beta cells of the islets of Langerhans in the pancreas. Its primary role is to regulate blood glucose levels by facilitating the uptake of glucose from the bloodstream into cells for energy or storage. However, insulin is not directly synthesized in its active form. Instead, the pancreatic beta cells begin by producing a precursor molecule called proinsulin.

Proinsulin is synthesized as a single polypeptide chain. Within these beta cells, a complex enzymatic process occurs where proinsulin is cleaved. This cleavage removes a connecting peptide, the C-peptide, revealing the mature, two-chain insulin molecule (composed of an A chain and a B chain). Simultaneously, the C-peptide is released. Therefore, for every molecule of insulin produced, an equimolar amount of C-peptide is also generated and secreted. This equimolar release is a key factor in why C-peptide is often a more reliable indicator of endogenous insulin secretion than insulin itself.

Proinsulin: The Precursor with Potential Significance

While the primary function of proinsulin is to serve as a precursor to insulin, research suggests it may possess some biological activity of its own, albeit significantly less potent than insulin. Studies have indicated that proinsulin has a biologic effect that is about one-tenth that of insulin. Furthermore, elevated levels of proinsulin, particularly in relation to C-peptide and insulin, can be indicative of certain pancreatic conditions. For instance, proinsulin levels above 5 pmol/l with blood glucose levels below 2.5 mmol/l during a 72-hour fast test can be a criterion for diagnosing specific disorders. The proinsulin molecule itself has a distinct structure, resembling a hairpin with an N-terminal and C-terminal that correspond to the A and B chains of mature insulin.

C-Peptide: A Robust Marker of Insulin Production

The C-peptide is often highlighted as a superior marker for assessing endogenous insulin production compared to measuring insulin levels directly. This is due to several factors. Firstly, insulin can be cleared by the liver, meaning the amount measured in the bloodstream might not accurately reflect the total amount produced by the pancreas. In contrast, C-peptide is not significantly cleared by the liver and has a longer half-life than circulating insulin (approximately 30 minutes for C-peptide versus a few minutes for insulin). This makes C-peptide a more reliable indicator of insulin secretion.

The C-peptide test measures C-peptide in your blood or urine and can help determine how much insulin your body makes. This is particularly useful in differentiating between type 1 and type 2 diabetes. In type 1 diabetes, the body's immune system attacks and destroys the insulin-producing beta cells, leading to very low or undetectable C-peptide levels. In type 2 diabetes, the body may still produce insulin, but it's not used effectively (insulin resistance), and C-peptide levels can be normal or even elevated initially.

Furthermore, C-peptide has no known biologic activity on its own, unlike proinsulin. Its presence and levels are solely a reflection of the pancreas's ability to synthesize insulin. The C-peptide test is valuable for diagnosing hypoglycemia (low blood glucose) and guiding diabetes management. In fact, C-peptide is better parameter than insulin level for certain diagnostic purposes, including diagnosing hypoglycemia.

Clinical Applications and Interpretations

The proinsulin vs. insulin vs. C-peptide ratio can provide significant diagnostic information. For example, the proinsulin-to-C-peptide ratio can offer insights into beta-cell function. Studies have shown that proinsulin-to-C-peptide ratios were stronger predictors of diabetes in certain populations compared to proinsulin-to-insulin ratios. The proinsulin to C-peptide (PI:C) ratio has been investigated in various conditions, including recent-onset type 1 diabetes.

In clinical practice, the C-peptide test is often preferred over an insulin test when assessing endogenous insulin production because C-peptide is a marker of endogenous insulin secretion, whereas insulin levels could also reflect exogenous insulin administration. This distinction is crucial for accurate diagnosis and treatment planning.

The Insulin Resistance Atherosclerosis Study (IRAS), among others, has explored the predictive value of these markers in relation to diabetes development and progression. The ability